Clinical Trial

Acoustic Resonance Therapy for Treating Empty Nose Syndrome

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is to determine whether Acoustic Resonance Therapy (ART), an FDA-approved treatment for standard nasal obstruction, may be helpful in mitigating the debilitating symptoms of Empty Nose Syndrome (ENS), which includes an alternative form of nasal obstruction. ART is a non-invasive treatment that uses sound vibrations to improve nasal congestion and other sinus symptoms. ART works by delivering specific frequencies of sound to the sinonasal cavities (nose and sinuses). These vibrations cause the tissues in the sinuses to resonate, which can help break up mucus and clear blockages, reduce inflammation, and improve airflow.
Trial Details
NCT Number NCT07215013
Lead Sponsor Stanford University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Empty Nose Syndrome, Nasal Obstruction
Enrollment 40 participants
Start Date 2028-07
Primary Completion 2030-07 (estimated)
Study Completion 2030-07 (estimated)
Updated on ClinicalTrials.gov 2025-10-10